世界の腫瘍臨床試験市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oncology Clinical Trial Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4606
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、腫瘍臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前立腺がん、肺がん、乳がん、白血病、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・腫瘍臨床試験の市場動向
・企業の競争状況、市場シェア
・腫瘍臨床試験の種類別市場規模と予測2016-2027（前立腺がん、肺がん、乳がん、白血病、その他）
・腫瘍臨床試験の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター）
・腫瘍臨床試験の北米市場規模2016-2027（アメリカ、カナダ）
・腫瘍臨床試験の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・腫瘍臨床試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・腫瘍臨床試験の中南米市場規模2016-2027（メキシコ、ブラジル）
・腫瘍臨床試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（IQVIA、Charles River Laboratory、ICON Plc、Medelis, Inc.、Medpace Holdings, Inc.、PAREXEL International、Pharmaceutical Product Development, LLC、Pivotal、PRA Health Sciences、Syneos Health）
・結論

Clinical trials are the final step in a long process that begins with research in a lab.
Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label.

Market Analysis and Insights: Global Oncology Clinical Trial Market
The global Oncology Clinical Trial market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Clinical Trial market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Clinical Trial market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Clinical Trial market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Clinical Trial market.

Global Oncology Clinical Trial Scope and Market Size
Oncology Clinical Trial market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Clinical Trial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prostate Cancer
Lung Cancer
Breast Cancer
Leukemia
Others

Segment by Application
Hospital
Clinic
Lab

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
IQVIA
Charles River Laboratory
ICON Plc
Medelis, Inc.
Medpace Holdings, Inc.
PAREXEL International
Pharmaceutical Product Development, LLC
Pivotal
PRA Health Sciences
Syneos Health

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2016-2027)
2.2 Oncology Clinical Trial Growth Trends by Regions
2.2.1 Oncology Clinical Trial Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Clinical Trial Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Clinical Trial Industry Dynamic
2.3.1 Oncology Clinical Trial Market Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2016-2021)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2020
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2016-2021)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2022-2027)

5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2016-2021)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oncology Clinical Trial Market Size (2016-2027)
6.2 North America Oncology Clinical Trial Market Size by Type
6.2.1 North America Oncology Clinical Trial Market Size by Type (2016-2021)
6.2.2 North America Oncology Clinical Trial Market Size by Type (2022-2027)
6.2.3 North America Oncology Clinical Trial Market Size by Type (2016-2027)
6.3 North America Oncology Clinical Trial Market Size by Application
6.3.1 North America Oncology Clinical Trial Market Size by Application (2016-2021)
6.3.2 North America Oncology Clinical Trial Market Size by Application (2022-2027)
6.3.3 North America Oncology Clinical Trial Market Size by Application (2016-2027)
6.4 North America Oncology Clinical Trial Market Size by Country
6.4.1 North America Oncology Clinical Trial Market Size by Country (2016-2021)
6.4.2 North America Oncology Clinical Trial Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2016-2027)
7.2 Europe Oncology Clinical Trial Market Size by Type
7.2.1 Europe Oncology Clinical Trial Market Size by Type (2016-2021)
7.2.2 Europe Oncology Clinical Trial Market Size by Type (2022-2027)
7.2.3 Europe Oncology Clinical Trial Market Size by Type (2016-2027)
7.3 Europe Oncology Clinical Trial Market Size by Application
7.3.1 Europe Oncology Clinical Trial Market Size by Application (2016-2021)
7.3.2 Europe Oncology Clinical Trial Market Size by Application (2022-2027)
7.3.3 Europe Oncology Clinical Trial Market Size by Application (2016-2027)
7.4 Europe Oncology Clinical Trial Market Size by Country
7.4.1 Europe Oncology Clinical Trial Market Size by Country (2016-2021)
7.4.2 Europe Oncology Clinical Trial Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2016-2027)
8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2016-2027)
9.2 Latin America Oncology Clinical Trial Market Size by Type
9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Clinical Trial Market Size by Type (2016-2027)
9.3 Latin America Oncology Clinical Trial Market Size by Application
9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Clinical Trial Market Size by Application (2016-2027)
9.4 Latin America Oncology Clinical Trial Market Size by Country
9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2016-2027)
10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2016-2021)
11.1.5 IQVIA Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2016-2021)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc
11.3.1 ICON Plc Company Details
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2016-2021)
11.3.5 ICON Plc Recent Development
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Details
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
11.4.5 Medelis, Inc. Recent Development
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Details
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
11.5.5 Medpace Holdings, Inc. Recent Development
11.6 PAREXEL International
11.6.1 PAREXEL International Company Details
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2016-2021)
11.6.5 PAREXEL International Recent Development
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Details
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2016-2021)
11.7.5 Pharmaceutical Product Development, LLC Recent Development
11.8 Pivotal
11.8.1 Pivotal Company Details
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2016-2021)
11.8.5 Pivotal Recent Development
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2016-2021)
11.9.5 PRA Health Sciences Recent Development
11.10 Syneos Health
11.10.1 Syneos Health Company Details
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2016-2021)
11.10.5 Syneos Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oncology Clinical Trial Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prostate Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Breast Cancer
Table 5. Key Players of Leukemia
Table 6. Key Players of Others
Table 7. Global Oncology Clinical Trial Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oncology Clinical Trial Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oncology Clinical Trial Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Oncology Clinical Trial Market Share by Regions (2016-2021)
Table 11. Global Oncology Clinical Trial Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Oncology Clinical Trial Market Share by Regions (2022-2027)
Table 13. Oncology Clinical Trial Market Trends
Table 14. Oncology Clinical Trial Market Drivers
Table 15. Oncology Clinical Trial Market Challenges
Table 16. Oncology Clinical Trial Market Restraints
Table 17. Global Oncology Clinical Trial Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Oncology Clinical Trial Market Share by Players (2016-2021)
Table 19. Global Top Oncology Clinical Trial Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Clinical Trial as of 2020)
Table 20. Ranking of Global Top Oncology Clinical Trial Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Oncology Clinical Trial Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Clinical Trial Product Solution and Service
Table 24. Date of Enter into Oncology Clinical Trial Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Oncology Clinical Trial Revenue Market Share by Type (2016-2021)
Table 28. Global Oncology Clinical Trial Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Oncology Clinical Trial Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Oncology Clinical Trial Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Oncology Clinical Trial Revenue Market Share by Application (2016-2021)
Table 32. Global Oncology Clinical Trial Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Oncology Clinical Trial Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Oncology Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Oncology Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Oncology Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Oncology Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Oncology Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Oncology Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Oncology Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Oncology Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Oncology Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Oncology Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oncology Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Oncology Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Oncology Clinical Trial Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Oncology Clinical Trial Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Oncology Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Oncology Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Oncology Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Oncology Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Oncology Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oncology Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Oncology Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Oncology Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Oncology Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 64. IQVIA Company Details
Table 65. IQVIA Business Overview
Table 66. IQVIA Oncology Clinical Trial Product
Table 67. IQVIA Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 68. IQVIA Recent Development
Table 69. Charles River Laboratory Company Details
Table 70. Charles River Laboratory Business Overview
Table 71. Charles River Laboratory Oncology Clinical Trial Product
Table 72. Charles River Laboratory Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 73. Charles River Laboratory Recent Development
Table 74. ICON Plc Company Details
Table 75. ICON Plc Business Overview
Table 76. ICON Plc Oncology Clinical Trial Product
Table 77. ICON Plc Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 78. ICON Plc Recent Development
Table 79. Medelis, Inc. Company Details
Table 80. Medelis, Inc. Business Overview
Table 81. Medelis, Inc. Oncology Clinical Trial Product
Table 82. Medelis, Inc. Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 83. Medelis, Inc. Recent Development
Table 84. Medpace Holdings, Inc. Company Details
Table 85. Medpace Holdings, Inc. Business Overview
Table 86. Medpace Holdings, Inc. Oncology Clinical Trial Product
Table 87. Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 88. Medpace Holdings, Inc. Recent Development
Table 89. PAREXEL International Company Details
Table 90. PAREXEL International Business Overview
Table 91. PAREXEL International Oncology Clinical Trial Product
Table 92. PAREXEL International Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 93. PAREXEL International Recent Development
Table 94. Pharmaceutical Product Development, LLC Company Details
Table 95. Pharmaceutical Product Development, LLC Business Overview
Table 96. Pharmaceutical Product Development, LLC Oncology Clinical Trial Product
Table 97. Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 98. Pharmaceutical Product Development, LLC Recent Development
Table 99. Pivotal Company Details
Table 100. Pivotal Business Overview
Table 101. Pivotal Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 102. Pivotal Recent Development
Table 103. PRA Health Sciences Company Details
Table 104. PRA Health Sciences Business Overview
Table 105. PRA Health Sciences Oncology Clinical Trial Product
Table 106. PRA Health Sciences Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 107. PRA Health Sciences Recent Development
Table 108. Syneos Health Company Details
Table 109. Syneos Health Business Overview
Table 110. Syneos Health Oncology Clinical Trial Product
Table 111. Syneos Health Revenue in Oncology Clinical Trial Business (2016-2021) & (US$ Million)
Table 112. Syneos Health Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Clinical Trial Market Share by Type: 2020 VS 2027
Figure 2. Prostate Cancer Features
Figure 3. Lung Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Leukemia Features
Figure 6. Others Features
Figure 7. Global Oncology Clinical Trial Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Lab Case Studies
Figure 11. Oncology Clinical Trial Report Years Considered
Figure 12. Global Oncology Clinical Trial Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Oncology Clinical Trial Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oncology Clinical Trial Market Share by Regions: 2020 VS 2027
Figure 15. Global Oncology Clinical Trial Market Share by Regions (2022-2027)
Figure 16. Global Oncology Clinical Trial Market Share by Players in 2020
Figure 17. Global Top Oncology Clinical Trial Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Clinical Trial as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Oncology Clinical Trial Revenue in 2020
Figure 19. Global Oncology Clinical Trial Revenue Market Share by Type (2016-2021)
Figure 20. Global Oncology Clinical Trial Revenue Market Share by Type (2022-2027)
Figure 21. North America Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Oncology Clinical Trial Market Share by Type (2016-2027)
Figure 23. North America Oncology Clinical Trial Market Share by Application (2016-2027)
Figure 24. North America Oncology Clinical Trial Market Share by Country (2016-2027)
Figure 25. United States Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oncology Clinical Trial Market Share by Type (2016-2027)
Figure 29. Europe Oncology Clinical Trial Market Share by Application (2016-2027)
Figure 30. Europe Oncology Clinical Trial Market Share by Country (2016-2027)
Figure 31. Germany Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oncology Clinical Trial Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Oncology Clinical Trial Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Oncology Clinical Trial Market Share by Region (2016-2027)
Figure 41. China Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oncology Clinical Trial Market Share by Type (2016-2027)
Figure 49. Latin America Oncology Clinical Trial Market Share by Application (2016-2027)
Figure 50. Latin America Oncology Clinical Trial Market Share by Country (2016-2027)
Figure 51. Mexico Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oncology Clinical Trial Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Oncology Clinical Trial Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Oncology Clinical Trial Market Share by Country (2016-2027)
Figure 57. Turkey Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Oncology Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. IQVIA Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 61. Charles River Laboratory Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 62. ICON Plc Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 63. Medelis, Inc. Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 64. Medpace Holdings, Inc. Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 65. PAREXEL International Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 66. Pharmaceutical Product Development, LLC Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 67. Pivotal Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 68. PRA Health Sciences Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 69. Syneos Health Revenue Growth Rate in Oncology Clinical Trial Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年）

Global Immuno Oncology Assays Market Size, Status and Forecast 2021-2027
QFJ1-4349 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、免疫腫瘍学アッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）、用途別市場規模（研究所、臨床診断）、主要地域別市場規模（北米、ア...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の血液腫瘍学検査市場規模・現状・予測（2021年-2027年）

Global Hemato Oncology Testing Market Size, Status and Forecast 2021-2027
QFJ1-5189 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、血液腫瘍学検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（白血病検査、急性骨髄性検査、多発性骨髄腫検査、その他）、用途別市場規模（臨床検査室、病院）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Oncology Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4604 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ...

世界の腫瘍診断用医療画像処理技術市場規模・現状・予測（2021年-2027年）

Global Medical Imaging Technologies for Oncology Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4473 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、腫瘍診断用医療画像処理技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（X線、磁気共鳴画像法（MRI）、核画像法、その他）、用途別市場規模（病院、クリニック、自立型クリニック、機器リース会社、その他...

世界のコンパニオン腫瘍診断市場規模・現状・予測（2021年-2027年）

Global Oncology Companion Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5273 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、コンパニオン腫瘍診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、免疫組織化学（IHC）、インサイチューハイブリダイゼーション（ISH...

世界の伴侶動物臨床化学分析市場規模・現状・予測（2021年-2027年）

Global Companion Animal Clinical Chemistry Analysis Market Size, Status and Forecast 2021-2027
QFJ1-4038 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、伴侶動物臨床化学分析の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（臨床化学試薬クリップ＆カートリッジ、臨床化学分析装置）、用途別市場規模（獣医参照研究所、獣医病院＆診療所、ポイントオブケア/社内検査...

世界の腫瘍小分子薬市場規模・現状・予測（2021年-2027年）

Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4607 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、腫瘍小分子薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学治療薬、免疫調節薬、標的治療薬、ホルモン療法、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）、主要...

世界の臨床分析におけるIT支出市場規模・現状・予測（2021年-2027年）

Global IT Spending on Clinical Analytics Market Size, Status and Forecast 2021-2027
QFJ1-3496 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、臨床分析におけるIT支出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（独立型、統合型）、用途別市場規模（支払者、提供者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5898 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、...

世界の個別化がんワクチン市場規模・現状・予測（2021年-2027年） Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells…
世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年） A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer. Market Analysis and Insights: Global Oncology Biomarker Market The global Oncology Biomarker marke…
臨床試験支援サービスのグローバル市場：規模・現状・予測2019-2025 The clinical trial support services provide the preclinical ground work and research such as patient recruitment, etc.In 2018, the global Clinical Trial Support Service market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …
臨床試験支援サービスのグローバル市場：規模・現状・予測2019-2025 The clinical trial support services provide the preclinical ground work and research such as patient recruitment, etc.In 2018, the global Clinical Trial Support Service market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …
世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…